Entax-20 20 mg Tablet Philippines - English - FDA (Food And Drug Administration)

entax-20 20 mg tablet

ambica international corporation; distributor: globo asiatico ent. inc. - tamoxifen (as citrate) - tablet - 20 mg

Tezoxil 3.5mg Powder for Solution fo Injection (IV/SC) Philippines - English - FDA (Food And Drug Administration)

tezoxil 3.5mg powder for solution fo injection (iv/sc)

ambica international crop.; distributor: globo asiatico ent. inc. - bortezomib - powder for solution fo injection (iv/sc) - 3.5mg

Allergenic Extract United States - English - NLM (National Library of Medicine)

allergenic extract

antigen laboratories, inc. - chaetomium globosum (unii: 5016wb8b8a) (chaetomium globosum - unii:5016wb8b8a) - chaetomium globosum 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Qi Chuan Hua Tan San Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

qi chuan hua tan san

tabib wee hong - rhizoma arisaema erubescens; herba ardisia japonica; folium eriobotrya japonica.; flos tussilago farfara .; flos gomphrena globosa; radix platycodon grandiflorum; bulbus fritillaria cirrhosa -

Fabrazyme ® 35mg (agalsidase beta) Singapore - English - HSA (Health Sciences Authority)

fabrazyme ® 35mg (agalsidase beta)

sanofi-aventis singapore pte. ltd. - agalsidase beta - injection, powder, for solution - 37.0mg/35mg vial - agalsidase beta 37.0mg/35mg vial

Fabrazyme ® 5mg (agalsidase beta) Singapore - English - HSA (Health Sciences Authority)

fabrazyme ® 5mg (agalsidase beta)

sanofi-aventis singapore pte. ltd. - agalsidase beta - injection, powder, for solution - 5.5mg/5mg vial - agalsidase beta 5.5mg/5mg vial

APPARENT CHAINSAW 250 HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apparent chainsaw 250 herbicide

titan ag pty ltd - hexazinone - soluble concentrate - hexazinone triazine-triazinones active 250.0 g/l - herbicide

Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva European Union - English - EMA (European Medicines Agency)

efavirenz/emtricitabine/tenofovir disoproxil zentiva

zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir